396 related articles for article (PubMed ID: 23613520)
21. Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.
Flynn EK; Kamat A; Lach FP; Donovan FX; Kimble DC; Narisu N; Sanborn E; Boulad F; Davies SM; Gillio AP; Harris RE; MacMillan ML; Wagner JE; Smogorzewska A; Auerbach AD; Ostrander EA; Chandrasekharappa SC
Hum Mutat; 2014 Nov; 35(11):1342-53. PubMed ID: 25168418
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
Jeong E; Lee SG; Kim HS; Yang J; Shin J; Kim Y; Kim J; Schärer OD; Kim Y; Yeo JE; Kim HM; Cho Y
Nucleic Acids Res; 2020 Apr; 48(6):3328-3342. PubMed ID: 32002546
[TBL] [Abstract][Full Text] [Related]
23. Severe telomere shortening in Fanconi anemia complementation group L.
Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
[TBL] [Abstract][Full Text] [Related]
24. Fanconi anemia core complex gene promoters harbor conserved transcription regulatory elements.
Meier D; Schindler D
PLoS One; 2011; 6(8):e22911. PubMed ID: 21826217
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
26. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
[TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
30. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
31. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
32. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
33. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
34. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
Taniguchi T; D'Andrea AD
Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
[TBL] [Abstract][Full Text] [Related]
35. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
[TBL] [Abstract][Full Text] [Related]
36. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
37. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
38. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
[TBL] [Abstract][Full Text] [Related]
39. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
40. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
